STAA STAAR SURGICAL CO Insider Trading

Broadwood Partners bought 670,213 shares in 3 tranches for $12.3M (avg $18.30) as stock down 34.1% from 52-week high.

Broadwood Partners, a director of STAAR Surgical, executed three separate purchases totaling 670,213 shares for $12,266,545.29 between March 11–13, 2026, at an average price of $18.30—well below the 52-week high of $28.57 but only 0.2% below the current price of $18.84. The company's fundamentals are distressed: annual revenue declined 23.7% year-over-year, the most recent full fiscal year was unprofitable, and the stock has fallen 21.9% over the past 90 days. Broadwood's prior trades at STAA—five buys in early January 2026—all posted negative 30-day returns (ranging from -19.9% to -21.9%), and none of the insider's broader cross-ticker buy history (20 prior buys with a 25% win rate at 90 days) demonstrated successful timing. This fresh accumulation in a deteriorating business environment, combined with a poor track record of buy timing at this specific ticker, suggests material risk rather than a conviction-driven inflection signal.

BROADWOOD PARTNERS (10% owner) buys 27,485 shares at $22.05; 5 buys in 3 days amid -26.0% drop from 52-week high.

BROADWOOD PARTNERS, a 10% owner of STAAR SURGICAL, executed 2 separate purchases totaling 27,485 shares for $606,137.70 on 2026-01-09, at an average price of $22.05 per share. This transaction is part of a concentrated buying pattern—the filer has made 5 purchases at this ticker over a 3-day window (2026-01-06 through 2026-01-09), adding 27,485 shares to holdings of 15.45M shares. The timing occurs against a backdrop of significant stock decline: the current price of $21.13 is -26.0% from the 52-week high of $28.57 and down -12.4% over the past 30 days. The company's fundamentals show quarterly revenue of $94.7M with net income of $8.9M, but full-year profitability was negative (full-year net income was negative), and annual revenue growth contracted -2.6% year-over-year. Across BROADWOOD's cross-ticker open-market trading history, the filer has recorded a 100.00% 90-day win rate on 20 prior buys with average 90-day returns of +10.1%, though measurable outcomes are not yet available for any of the 5 same-ticker trades at STAA.

Broadwood Partners accumulates 406,653 STAA shares across 4 days for $8.8M as stock declines 11.4% in 30 days.

Broadwood Partners, a 10% shareholder, executed 8 separate purchases totaling 406,653 shares (406.7K shares) over 4 days (January 6–8, 2026) at prices ranging from $21.01 to $22.38, spending $8,817,663.73. The blended average purchase price of $21.68 sits above the current price of $22.50 and reflects buying activity during a 30-day decline of -11.4%. At STAA specifically, the insider's 5 prior buys over the preceding week (November 19–21) have returned -5.0% to -10.2% at the 30-day mark, with measurable 90-day outcomes still pending. The company reported negative full-year net income despite quarterly revenue of $94,732,000.00 ($94.7M) and faces annual revenue contraction of -2.6%. The multi-transaction structure and large capital deployment ($8.8M) during a period of weakening stock price and negative fundamentals merit attention to understand the buyer's assessment of valuation and near-term prospects.

Broadwood Partners purchases 1,500,000 shares for $41.1M at STAA; 10% holder adds 11.1% to holdings over 3 days

Broadwood Partners, a 10% shareholder, executed three separate open-market purchases totaling 1,500,000 (1.50M shares) over November 19–21 at a blended average price of $27.37, increasing holdings from 13,519,491 to 15,019,491 shares (+11.1%). The transaction size ($41,060,317.10) represents a material capital commitment, executed across three tranches at progressively higher prices ($26.42, $27.14, and $27.86). Notably, this insider's prior five trades at STAA were all well-timed, with all 5 of 5 prior buys producing positive 90-day returns (ranging from +6.6% to +12.9%). The current stock price of $28.00 sits 3.8% below the 52-week high of $29.10 but 12.4% above the 30-day average, and the company reported revenue of $94,732,000 and net income of $8,884,000 in the latest quarter, though full-year net income was negative. The sequential price escalation during the purchase window and the consistent pattern of prior well-timed buys at this ticker merit investor attention.

10% owner BROADWOOD PARTNERS bought 187,227 shares for $2,866,428.46 across 4 days at avg $15.31 vs stock now -70.2% from 52-wk high

BROADWOOD PARTNERS, L.P., a 10% owner, executed 8 separate purchases totaling 187,227 shares for $2,866,428.46 ($2.9M) between April 8–10, 2025, at a blended average price of $15.31, increasing its holdings from 13.33M to 13.52M shares. The timing coincides with acute price weakness: STAAR's stock is currently -70.2% from its 52-week high of $52.25 and down -15.1% in the past 30 days and -32.3% in the past 90 days. The company's fundamentals reflect deterioration—revenue declined -2.6% year-over-year, and it reported negative full-year net income despite recent quarterly profitability of $10.0M on $88.6M revenue. BROADWOOD's previous 5 same-ticker trades at STAA are all recent buys (April 4–7, 2025) with outcomes not yet measurable, indicating sustained accumulation into a depressed market for the stock.

STAA: 10% owner Broadwood Partners bought 845,220 shares (5 transactions) for $13,627,504.30 in early April, expanding holdings to 13.33M shares (+6.8%)

Broadwood Partners executed 5 separate purchases totaling 845,220 shares for $13,627,504.30 across April 2–7, 2025, at an average price of $16.12, reflecting a coordinated accumulation into STAA at levels near the 52-week low of $15.35. The stock has declined -69.1% from its 52-week high of $52.25, and the company is operating in a weak fundamental environment with annual revenue declining -2.6% and full-year net income negative. This series of discretionary open-market purchases by a 10% holder during a sharp drawdown is noteworthy given that the stock continues to trade -12.0% lower over the 30-day window and -32.4% lower over 90 days, and the prior five STAA trades by Broadwood are too recent to measure outcomes. The scale of this accumulation (adding 6.8% to existing holdings) by a major shareholder during a period of fundamental deterioration and share-price weakness is material to consider.

Broadwood Partners bought 53,969 shares (54.0K) for $941,285.43 across 4 transactions, expanding 12.49M position

Broadwood Partners, a 10% owner of STAA, executed 4 separate purchases totaling 53,969 shares for $941,285.43 at an average price of $17.44, adding 0.4% to its holdings of 12,487,044 shares post-transaction. The purchases occurred on 2025-03-31 and 2025-04-02 at prices ($17.46 and $17.43) near current levels ($17.60), representing transactions within a modest range during a period when the stock trades 66.3% below its 52-week high of $52.25. The company's fundamentals show recent quarterly revenue of $88,590,000.00 and net income of $10,000,000.00, though full-year results were negative. Prior activity at this ticker shows 5 buy transactions since 2025-03-26, all too recent for 90-day performance measurement, while the insider's broader cross-ticker buy history spans 20 prior transactions, with no measurable timing outcomes yet at this specific ticker.

10% owner BROADWOOD PARTNERS bought 113,384 shares in 3 tranches (Mar 26-28) for $1,983,823.66 at avg $17.50

BROADWOOD PARTNERS, L.P., a 10% owner, executed 3 separate purchases totaling 113,384 shares for $1,983,823.66 over March 26-28, at prices near $17.50. This represents a +0.9% increase to the holder's 12.43M-share position. The purchases occurred amid significant recent price pressure: the stock is -66.0% from its 52-week high of $52.25 and down -26.5% over the past 90 days, though it has recovered +4.1% over the past 30 days. Fundamentally, STAAR is challenged: annual revenue growth is -2.6%, the company was unprofitable over its most recent full fiscal year, and the latest quarterly revenue is $88.6M with net income of $10.0M. The insider's prior 5 trades at this ticker (all within the past week, Mar 20-25) show no measurable outcomes yet. Without timing context or trading-plan disclosures, the pattern of repeated accumulation in a down-trending, unprofitable company warrants investor attention to whether this signals value-hunting by a major shareholder or reflects forward-looking conviction despite near-term headwinds.

10% owner Broadwood Partners buys 136,696 shares ($2.4M) at blended average $17.66 across 4 transactions as stock trades at $17.46, -66.6% from 52-week high.

Broadwood Partners, holding 12.32M shares (approximately 10% of STAAR Surgical), executed 4 separate purchases totaling 136,696 shares for $2,414,722.39 between March 18–25, 2025, at a blended average price of $17.66. The purchases occurred as the stock trades at $17.46 and stands at -66.6% from its 52-week high of $52.25, suggesting a significant retracement from recent peaks. STAA's fundamentals show recent headwinds: the company posted -2.6% annual revenue growth, recorded a full-year net loss, and the stock is down 30.1% over the prior 90 days. The timing of Broadwood's purchases coincides with five prior purchases at this ticker since March 18, indicating sustained acquisition activity during this depressed valuation window. Without access to scheduled trading plan details or management guidance, the purchase pattern reflects a substantial commitment of capital by a major shareholder into a stock trading well below its recent range.

Broadwood Partners buys 201,844 shares ($3.6M) at STAA after 65.7% decline from 52-week high

Broadwood Partners, a 10% owner at STAAR SURGICAL, executed 6 purchases totaling 201,844 shares for $3,586,282.98 across March 18–20, 2025, at an average price of $17.77 per share. This represents a 1.7% increase in holdings (from 11,981,151 to 12,182,995 shares). The timing follows a sharp decline: STAA is currently -65.7% from its 52-week high of $52.25, though it has recovered 7.8% over the past 30 days. The company faces fundamental headwinds—annual revenue declined 2.6% year-over-year and it was unprofitable over its most recent full fiscal year—making valuation considerations relevant context for the buy. Broadwood's own cross-ticker track record shows an average 30-day return of +8.9% on prior open-market buys, though its five prior trades at STAA (all on 2025-03-03 and 2025-03-04) remain unmeasurable at both 30 and 90 days. This filing adds to a pattern of accumulation at STAA within a narrow time window and at depressed valuations relative to recent history.